GB0522075D0 - Process for preparing almodipline mesylate monohydrate - Google Patents

Process for preparing almodipline mesylate monohydrate

Info

Publication number
GB0522075D0
GB0522075D0 GBGB0522075.1A GB0522075A GB0522075D0 GB 0522075 D0 GB0522075 D0 GB 0522075D0 GB 0522075 A GB0522075 A GB 0522075A GB 0522075 D0 GB0522075 D0 GB 0522075D0
Authority
GB
United Kingdom
Prior art keywords
almodipline
preparing
mesylate monohydrate
mesylate
monohydrate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GBGB0522075.1A
Other versions
GB2415696B (en
GB2415696A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cipla Ltd
Original Assignee
Cipla Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0309471A external-priority patent/GB0309471D0/en
Priority claimed from GB0314617A external-priority patent/GB0314617D0/en
Application filed by Cipla Ltd filed Critical Cipla Ltd
Publication of GB0522075D0 publication Critical patent/GB0522075D0/en
Publication of GB2415696A publication Critical patent/GB2415696A/en
Application granted granted Critical
Publication of GB2415696B publication Critical patent/GB2415696B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GB0522075A 2003-04-25 2004-04-16 Process for preparing amlodipine mesylate monohydrate Expired - Fee Related GB2415696B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0309471A GB0309471D0 (en) 2003-04-25 2003-04-25 Process
GB0314617A GB0314617D0 (en) 2003-06-23 2003-06-23 Process
PCT/GB2004/001638 WO2004096770A1 (en) 2003-04-25 2004-04-16 Process for preparing almodipine mesylate monohydrate

Publications (3)

Publication Number Publication Date
GB0522075D0 true GB0522075D0 (en) 2005-12-07
GB2415696A GB2415696A (en) 2006-01-04
GB2415696B GB2415696B (en) 2007-06-20

Family

ID=33420880

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0522075A Expired - Fee Related GB2415696B (en) 2003-04-25 2004-04-16 Process for preparing amlodipine mesylate monohydrate

Country Status (6)

Country Link
AR (1) AR044063A1 (en)
CL (1) CL2004000864A1 (en)
DE (1) DE112004000712T5 (en)
GB (1) GB2415696B (en)
PA (1) PA8601501A1 (en)
WO (1) WO2004096770A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1152013C (en) * 2001-11-22 2004-06-02 张喜田 Levo-amlodipine salt able to generate hydrate and its hydrate and preparation
US20230023131A1 (en) * 2019-12-09 2023-01-26 Kunming Sinoway Natural Pharmaceuticals Co., Ltd. Amlodipine mesylate monohydrate preparation method therefor and use thereof
CN112538044B (en) * 2019-12-09 2021-08-13 昆明赛诺制药股份有限公司 Amlodipine mesylate monohydrate, and preparation method and application thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK161312C (en) * 1982-03-11 1991-12-09 Pfizer CHANGES FOR THE PREPARATION FOR THE PREPARATION OF 2-Amino-CO-Methyl-4-Methyl-4-Methyl-4-Methyl-4-Methyl-4-Methyl-4-Methyl-2-D-Hydroxy
GB8608335D0 (en) * 1986-04-04 1986-05-08 Pfizer Ltd Pharmaceutically acceptable salts
EP1221438B1 (en) * 2001-01-09 2007-03-14 Siegfried Generics International AG Amlodipine mesylate salts

Also Published As

Publication number Publication date
DE112004000712T5 (en) 2006-10-19
GB2415696B (en) 2007-06-20
PA8601501A1 (en) 2004-12-16
GB2415696A (en) 2006-01-04
CL2004000864A1 (en) 2005-04-22
WO2004096770A1 (en) 2004-11-11
AR044063A1 (en) 2005-08-24

Similar Documents

Publication Publication Date Title
IL172331A0 (en) Processes for preparing 3-benzazepines
HK1073110A1 (en) Process for preparing aripiprazole
IL183568A (en) Process for preparing 7,8-dihydro-5h-pteridin-6-one derivatives
IL173456A0 (en) Process for the preparation of 4-amino-3-quinolinecarbonitriles
PT1720832E (en) Process for preparing n-protected 4-ketoproline derivatives
IL178233A0 (en) Process for producing 5-hydroxy-4-thiomethylpyrazole derivatives
IL174029A0 (en) Process for preparing 2-oxo-1-pyrrolidine derivatives
IL169879A0 (en) Process for preparing pyrrolotriazine derivatives
HK1078863A1 (en) Process for preparing (s)-pantoprazole
HK1099298A1 (en) Improved process for preparing rebamipide
SG137677A1 (en) Improved process for preparing polyalkenylsuccinimides
MY137678A (en) Process for preparing formaldehyde
IL175743A0 (en) Process for the preparation of thiazolopyrimidines
IL175966A0 (en) Process for preparing aripiprazole
IL178069A0 (en) Process for preparing n-aryl-piperazine derivatives
EP1612213A4 (en) Process for producing 2 -deoxy-2 -fluorouridine
GB0416694D0 (en) Process for preparing microcrystals
EP1507781A4 (en) Process for preparing maytansinol
GB0522075D0 (en) Process for preparing almodipline mesylate monohydrate
HK1095145A1 (en) Process for the preparation of n-arylmorpholinones n-
IL183804A0 (en) Process for preparing substituted 2-alkoxycarbonyl-3-aminothiophenes
AU2003248987A8 (en) Process for preparing 7-azaindoles
GB2412373B (en) Process for preparing guggulsterones
ZA200508752B (en) Process for preparing amlodipine mesylate monohydrate
HK1087111A1 (en) Process for the preparation of nicotinaldehydes

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20130416